Please login to the form below

Not currently logged in
Email:
Password:

ASH 2018

This page shows the latest ASH 2018 news and features for those working in and with pharma, biotech and healthcare.

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

new data at the ASH 2018 congress in multiple myeloma. ... Amgen also reported data at ASH on another BiTE candidate called AMG 330 which targets CD33, the same target as Regeneron’s REGN1979 which posted results in lymphoma earlier during the

Latest news

  • Regeneron’s early stage bispecific shows promise Regeneron’s early stage bispecific shows promise

    Regeneron is one many companies developing bispecifics, and on Saturday at the ASH 2018 congress in San Diego, unveiled phase 1 proof of concept data for its REGN1979 in relapsed or ... Also presenting bispecific antibodies at ASH are Amgen (AMG 420) and

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Highlights in haematologic malignancy from ASH 2018

    The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. ... If you would like to discuss insights from ASH 2018 or have any

  • Porterhouse Medical Group

    Highlights in haematologic malignancy from ASH 2018. ... To support World AIDS Day 2018 and to help tackle the stigma surrounding the condition, Porterhouse Medical explores the misconceptions surrounding HIV/AIDS.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics